ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 050 JPY 0.69% Market Closed
Market Cap: 58.1B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

ASKA Pharmaceutical Holdings Co Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ASKA Pharmaceutical Holdings Co Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
PP&E Net
ÂĄ11.3B
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
PP&E Net
ÂĄ1.9T
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
13%
Daiichi Sankyo Co Ltd
TSE:4568
PP&E Net
ÂĄ458.4B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
4%
Otsuka Holdings Co Ltd
TSE:4578
PP&E Net
ÂĄ578.8B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
PP&E Net
ÂĄ426.4B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
12%
Astellas Pharma Inc
TSE:4503
PP&E Net
ÂĄ315.3B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
5%
No Stocks Found

ASKA Pharmaceutical Holdings Co Ltd
Glance View

Market Cap
58.1B JPY
Industry
Pharmaceuticals

ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.

Intrinsic Value
3 410.94 JPY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's PP&E Net?
PP&E Net
11.3B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's PP&E Net amounts to 11.3B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
-4%

Over the last year, the PP&E Net growth was 4%. The average annual PP&E Net growth rates for ASKA Pharmaceutical Holdings Co Ltd have been -4% over the past three years , -4% over the past five years .

Back to Top